尼沃卢马布诱导的牛皮的临床特征,治疗和结果
Shaoli Zhao1,2, Wei Sun3, Jichun Sun4
1Department of Endocrinology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, 410013, China.
Investigational new drugs
|December 26, 2024
概括
牛皮是nivolumab的一个不常见的副作用. 这项研究分析了55名患者,发现斑块性牛皮是最常见的,并强调需要监测和及时治疗.
科学领域:
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
- 在瘤学瘤学.
背景情况:
- 牛皮是一种与nivolumab相关的免疫媒介不良事件.
- 尼沃卢马布诱导的牛皮的临床特征尚不清楚.
研究的目的:
- 为了研究由nivolumab引起的牛皮的临床特征和模式.
- 为识别和管理这种情况提供见解.
主要方法:
- 对案例报告和案例系列的回顾性分析.
- 搜索了中国和英语数据库,直到2024年6月30日.
- 包括55名患有尼沃卢马布相关的牛皮的患者.
主要成果:
- 平均年龄为65岁; 80.0%是男性.
- 38人 (69.1%) 患有新发的牛皮,17人 (30.9%) 患有恶化.
- 主要类型:斑块性牛皮 (65.5%),牛皮关节炎 (20.0%),棕植物性牛皮 (16.4%).
- 发病的中位时间为28天.
- 52名 (94.5%) 患者通过干预得到改善.
结论:
- 尼沃卢马布可以诱导牛皮,斑块牛皮是最常见的呈现形式.
- 密切监测尼沃卢马布治疗患者的牛皮的出现对于及时诊断至关重要.
- 根据临床情况进行适当的局部或全身治疗可以改善结果.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
141
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
141
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
115
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
115
Inflammatory Bowel Disease IV: Pharmacological Management
111
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
111
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
315
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
315
Skin Cancer
3.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
3.1K


